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“I’m glad that after the German G7 presidency global health is now also going to be a 
priority under our G20 presidency. With this decision taken by our Federal Chancellor, Angela 
Merkel, a global health policy is going to be a hallmark of our country’s international 
responsibility. Only if we cooperate can we really prepare the world for future health crises” 
Federal Health Minister Hermann Gröhe1 
 
Abstract 
Over the past ten years, Germany has become a more visible actor in Global Health, but 
little academic research exists analysing this development. This article attempts to fill this 
gap, by describing how this shift is complementary to a broader change in perspective in 
German foreign policy. Catalysts for this shift have been strong leadership at the top, a 
window of opportunities through G7/20 presidencies and the Ebola outbreak. We propose 
four characteristics of German global health engagement. These are to a large extent 
congruent with the approaches and goals of the SDG-agenda for health. The combination of 
momentum and specific characteristics makes the country well equipped to become a 
leader in global health. Yet, it needs to accept a larger financial responsibility for global 
health, expand its domestic global health competencies, reduce fragmentation of global 
health policy making, and solve major incoherencies in its policies. at home and abroad. 
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6 Key Messages 
1. Germany entered the global health debate late as compared to some other G7 countries, 
but the country’s visible financial and political engagement has grown over the past decade 
complemented by a shift in foreign policy and propelled by stronger political leadership and 
the Ebola outbreak.  
2. Germany’s global health agenda is congruent with the SDG agenda, it is rooted in a 
human rights approach, multilateralism, the Bismarck model of social protection, and a link 
between development and investment based on its own trajectory. 
3. Germany’s multilateral orientation in foreign policy makes it likely that global health 
engagement will continue to be a priority, but to claim leadership in global health Germany 
must ramp up its financial commitments to soon reach the 0.1 percent target of official 
development assistance for health. 
4. Policy incoherencies in domestic policies (e.g. access of refugees/migrants to health 
services) and international policies (e.g. international tobacco regulation) remain and need 
to be resolved to correspond to Germanys values in global health policy. 
5. Germany’s domestic global health expertise is still limited and needs to be strengthened 
to effectively build partnerships and alliances across sectors as well as to integrate global 
health consistently in its foreign policy strategy. 
6. Germany’s strong capacities in health research are under-utilized for cooperation with 
developing countries. Institutionalised funding for “African-German” health research and 
education partnerships on poverty related diseases would strongly support Germany’s role 
in global health and achieving the SDGs. 
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1 A new context  
The G20 Summit hosted this year by Germany is overshadowed by discussions on global 
uncertainty and protectionism. There are many indications that the United States is no 
longer willing to support an agenda that upholds multilateralism, globalization, and free 
trade and will possibly reduce its foreign aid contributions radically. In anticipation of those 
developments, the Munich Security Conference in February 2017 gave the clear signal that 
Europe will need to take on more global responsibility and that Germany in particular is 
challenged to act.2  
This general trend also applies to global health. There is mounting concern that the golden 
era of global health - which was closely linked to globalization and interconnectedness - has 
come to an end.3 Financial contributions are stagnating and the largest global health funders 
- the USA and the United Kingdom (UK) - might not retain their political and financial 
commitments due to pressures to invest "at home".4,5 All eyes are now on Germany which 
has recently taken on a political leadership role through its presidencies of the G7 and G20 
summits and in the context of the World Health Organization (WHO). There is a strong 
expectation that in the new political environment, its global health responsibilities - political 
and financial - are set to grow in both the multilateral and the bilateral arena.  
Indeed, Germany is one of the few countries still determined to expand its global 
engagement and increase funding for development and global initiatives as the most recent 
budget figures for 2018 confirm.6 This is a strong political statement which gives some hope 
to global health advocates. But while Germany has almost doubled its global health 
spending in the last 10 years (see sections 2 and 3) and has significantly contributed to 
humanitarian health responses, it is still far removed from the 0.1 % goal of development 
assistance for health. The priorities Germany will set for global health cooperation will be 
just as critical as the funding commitments. How will these commitments support the 
Sustainable Development Goals (SDGs) and the United Nations system? How will the 
European Union (EU) move forward? What alliances will emerge with other countries and 
stakeholders? To all effect its diplomatic representations in Geneva and New York have 
been active in global health diplomacy as never before.  
Germany has long been a reliable, yet rather silent actor in development cooperation 
providing continued support to health systems strengthening. Only recently has it become a 
prominent voice in promoting global collective responsibility in health. This became evident 
as it took the step to prioritize health in the German G7 presidency in 2015 and followed 
through with the 2017 G20 agenda “Shaping an interconnected world."7 In recent months 
Berlin has become a hub for global health conferences which will - for the first time ever in 
the G20 context - culminate in a meeting of G20 health ministers at the end of May 2017. 
The ministers will focus their discussions on strengthening health systems and on two cross-
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border health issues: the fight against antimicrobial resistance (AMR) and the creation of 
mechanisms to prevent the outbreak of pandemics.8 Their recommendations will go to the 
heads of government in Hamburg in July of 2017. One political goal for Germany is to 
achieve continuity for the health debate within G20 and to establish a permanent global 
health group in view of the high relevance health has for the economy, the security and the 
wellbeing of countries.  
Global health can be understood as "those health issues that transcend national boundaries 
and governments and call for actions on the global forces that determine the health of 
people."9 As the German G20 documents link health to interconnectedness, they follow an 
understanding of global health that is broader than development cooperation. It is not easy 
to track the origins of this shift in mindset because - with few exceptions - no significant 
literature or analysis of Germany's role in global health exists.10 As is the case for many 
countries, describing Germany's role in development cooperation for health and its 
contribution to international organisations is easier than exploring the full scope of its global 
health actions, which would include the impact of determinants of health and activities in 
sectors other than health, particularly areas such as more equitable trade and finance 
policies and most recently austerity and migration policies. These in particular are made 
more complex because they are also negotiated within an EU context. 
The new priority the German federal government’s has given to global health has, in 
principle, met with broad approval. There remain concerns, however, among influential 
non-governmental organizations (NGOs) and leading global health academics that 
Germany's long term commitment to strengthening health systems might be weakened and 
investments might shift towards a narrow focus on health security.11 Outside observers of 
governmental action in the field of global health have thus called for an assurance that the 
German commitment to protection of human rights and of sexual and reproductive health 
and rights will remain strong, as will the commitment to poverty reduction and to 
multilateralism.12  
Civil society networks like the German Platform for Global Health continue to urge for a 
much stronger strategic connection between health inequalities in Germany, Europe, and 
worldwide and are highly critical of the health impact of Germany-led austerity policies 
within the European Union as well as of a more restrictive refugee and migration policy.13 
They are also concerned that statements will be adopted by other G20 ministerial meetings 
which could have a negative impact on health, especially in low and middle income 
countries.14 The growing civil society activism on issues of global health expects the German 
government to address these issues in the next phase of German global health activities as 
they argue for a broad agenda on global health that reaches beyond biomedical and health 
security perspectives and addresses the broad range of social, cultural, economic and 
political determinants of global health. 
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2 Why Germany is a latecomer to the international global health debate 
Germany's role as a latecomer can be attributed to a mix of factors. First, for a long time, 
health cooperation in the European Union had a much higher priority for the German 
Ministry of Health, ministers were not interested in and got no kudos for engaging in 
international health. In consequence, the ministry only had a very weak office of 
international health and no budget to speak of for activities in this field. Second, budgets for 
international health development resided with German development assistance and there 
was little if any cooperation with other ministries and agencies. Third, the Millennium 
Development Goal (MDG) type vertical global health approach did not sit well with the 
German health systems-oriented approach and its prioritization of the WHO. Fourth, there 
was no strong academic base for global health. Fifth, priority global issues defined by the 
ministry of foreign affairs did not include health and were initially focused on global 
environmental policies. Lastly, Germany's unique geo-political position required direct 
support and investments to the countries of Central and Eastern Europe and cooperation 
within the EU. 
Germany's global role is very recent and cannot be understood without reference to its 
history and to foreign policy developments after World War II. Its development as a nation-
state is defined by contradictions, disruptions, and great crimes against humanity. It is often 
difficult for other countries to fully comprehend the extent to which the historical burden of 
the Nazi Regime is present in the German political debate and still defines German actions. 
The former German Minister of Foreign Affairs and current President of Germany, Frank-
Walter Steinmeier re-iterated this position in a recent op-ed in Foreign Affairs: "Our 
historical experience has destroyed any belief in national exceptionalism—for any nation."15 
Any claim for a political leadership role is rapidly challenged both from within and outside of 
Germany. Even decades after World War II Germany did not actively seek a role as a global 
leader but chose an "under the radar" path preferably within the multilateral system and 
whenever possible together with others, especially as an EU member state.  
The historical steps towards the recent expansion of its international role can be roughly 
analysed in 20 year periods: the post-war foreign policy focus was to be a reliable partner in 
the Western Alliance and to construct and strengthen European cooperation; from 1969 a 
ground-breaking shift led to the normalization of relations between West Germany, East 
Germany and Eastern Europe, called "Ostpolitik"; yet another major reorientation came 
with the fall of the Berlin Wall in 1989 and German reunification which led to Germany's 
new - and not always welcome - strength within the European Union especially since the 
Maastricht Treaty of 1992. Its role was to be a regional power constrained by and within the 
EU. It was only under the leadership of Minister Joschka Fischer (1998 - 2005) that the 
German foreign office began to engage prominently in global issues.  
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In the global political arena, Germany became a determined leader on environmental issues 
- not global health. Questions around environmental protection gained increasing relevance 
in domestic politics and Germany established a Ministry for the Environment (BMU) after 
the Chernobyl disaster in 1986. It soon engaged forcefully in that new global policy arena 
which provided space for pioneer countries and was populated by few other established 
actors.16 Germany was able to bring domestic environmental innovations and intellectual 
resources to the global level, it gained the directorships of United Nations Environment 
Programme (UNEP) in the period between 1998 to 2016, and contributed significantly to the 
crafting of international agreements including The Earth Summit in Rio 1992 and most 
recently the Paris agreements in 2015.17 
A global role and a more assertive German foreign policy is associated with Germany's 
refusal - as chair of the UN Security Council in 2003 - to agree to the invasion of Iraq. With 
the response to the 2007 financial crisis and the 2015 response to the refugee crisis, 
Germany's new strong role in Europe and beyond became even more evident, a 
development that "attracts praise and criticism in equal measure."18 German political 
leaders like to present this shift as a force of circumstance, rather than Germany seeking a 
new role, but its strong export-oriented economy requires a high degree of free trade and 
close communication with countries in Europe and across the world.19 The approach was to 
develop a new foreign policy orientation through various government white papers.20 The 
new direction was expressed forcefully to an international audience by the German 
President Gauck at the opening of the 50th Munich Security Conference in 2014 when he 
stated: "Germany must be prepared to do more."21 The priority areas for expansion 
identified by the government are what has been termed the two dimensions of security: 
defence and development spending.22 The most recent budget plan for 2018 reflects this: it 
indicates an increase of both development and defence spending (see a an overview of 
German ODA spending in the Web-Appendix).23  
Link to Web-Appendix about here: Germany’s ODA spending 2005-15  
3 Recent catalysts of German global health engagement  
Germany began to systematically step up its activities to co-shape the global health agenda, 
engage in the governance of global health organisations and co-create and support new 
initiatives about ten years ago. This change is also reflected in the extended financial 
commitments to both, funds for global health and total ODA spending (figure 1). The growth 
in German ODA spending is remarkable, given that other G7 countries – except for the UK 
which has enshrined the 0.7 goal as law – did not increase their overall ODA budgets in real 
terms in this period (see vertical axis). ODA for health increased significantly in Germany (94 
percent), the UK (136 percent), and the USA (97 percent) while there was much lower 
growth in the other G7 countries – or even a decline as in Italy.24 
7 
 
 
 
Figure 1 about here: Growth of ODA for health vs. Growth of total ODA, 2005-15 
For Germany taking the step from development cooperation for health to broader global 
health action was linked to three exceptional factors: the personal commitment of the head 
of government, a unique window of political opportunity for leadership, and the disastrous 
outbreak of the Ebola virus. 
The German Chancellor as a health leader  
Chancellor Merkel’s personal drive and interest is a unique feature25 of the increasing 
involvement of Germany in global health, especially since the 2007 G8 Heiligendamm 
Summit. Its key motivation is not that different from what led to Germany's leadership on 
the environment: the recognition of interconnectedness in the era of globalization. Global 
health - as the German government approaches it in the recent G7 and G20 context - aims 
to reduce the health risks that come with global interdependence for people living in 
Germany and at the same time to ensure healthy lives for populations elsewhere. In her 
speech at the 51st Munich Security Conference in 2015, Angela Merkel put the threatening 
nature of Ebola in one line with other global issues such as global terrorism and forced 
migration and spoke about  “[…] the extent to which foreign and security policy impacts 
matters concerning the internal politics of our societies.”26 Global Health is linked to 
priorities in domestic policy, such as AMR; is an area where Germany can share successful 
experiences, especially in social health protection, and is an attractive policy field which 
reflects German foreign policy principles. It allows Germany to demonstrate soft power, 
collaborate with other key players beyond traditional alliances, and contribute to building a 
global consensus and global solutions. This is why - following the Ebola outbreak - Germany 
championed not only national health security, but the strengthening of WHO and the better 
coordination of UN organisations.27,28 
The G7/G20 as a window of opportunity  
An exceptional window of opportunity opened for German leadership through the proximity 
of the G7 and G20 presidencies to put health high on the political agenda of heads of state 
and government and to engage many other stakeholders through the related processes. The 
German government had already put the issue of AMR on the G7 agenda, continued the 
focus on health systems strengthening and included the research agenda for neglected 
tropical diseases in the years preceding the German G7 presidency in 2015. It also 
spearheaded a highly successful the GAVI replenishment in 2015. When the seriousness of 
the outbreak of Ebola virus disease (EVD) in 2014/2015 became evident Germany grasped 
the opportunity to become a champion for global health security with the strong personal 
involvement of the chancellor. It has also worked with Japan to promote the integration of 
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the Universal Health Care (UHC) and the health security agenda witnin their G7 presidency 
in 2016 and was able to ensure continuity of the global health agenda through the meeting 
of G20 health ministers in 2017. 
Ebola virus disease outbreak 2014/15 as a major catalyst for German health security 
engagement  
With the Ebola virus disease outbreak 2014/15, global health security became an issue of 
national concern for the German government and an entry point for broader German 
commitment to global health including the strengthening of health systems. Like other 
countries Germany had responded very late to the Ebola crisis - it then took an active role in 
supporting the affected countries under the lead of the Ministry of Foreign Affairs, who 
appointed a special ambassador for coordination of the German government in its response 
to the Ebola outbreak. 
Despite Germany’s long-standing – but not prominent – membership of both the Global 
Health Security Initiative of 2002, committed to chemical, biological, radiological and 
nuclear preparedness and the Global Health Security Agenda of 2014, committed to IHR 
strengthening,29 the country still has a long way to go domestically to achieve an agreed and 
integrated policy approach to global health security so as to be fully prepared in case of an 
outbreak.  
The list of the German activities and contributions to health security internationally is 
extensive and encompasses a range of German ministries. Most entries in this list are post-
Ebola. They include support to the High-Level Panel on Global Response to Health Crisis and 
the UN Global Health Crisis Task Force,30  contributions to the WHO Contingency Fund for 
Emergencies (CEF)31 and pledges to fund the early phase of the Pandemic Emergency 
Financing Facility (PEF).32 In early 2017 Germany joined Japan, Norway, the Wellcome Trust 
in contributing to the first five-year budget for the research and development initiative of 
the Coalition for Epidemic Preparedness Innovations (CEPI) which will focus on research and 
stockpiling of vaccines.33 Health security is now a component of the agenda of the Munich 
Security Conference, including the attacks on health facilities and health workers.34  
Strong concern remains that health security could be prioritized nationally as well as 
internationally at the expense of investments in UHC. In an advocacy paper by VENRO 
(Verband Entwicklungspolitik Deutscher Nichtregierungsorganisationen) and Médecins Sans 
Frontières published in 2017, the two organizations state that the G20 needs to regard 
health not just as an outcome of human development, but also a precondition, and that 
“[h]ealth is more than crisis management: Every person has a right to health.”35 
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4 The roots of German health engagement 
Germany was a late comer to global health for various reasons (see section 2) and remained 
a rather silent actor as it did not play a major role in launching and financing high visibility 
disease-specific initiatives in the early 2000s. It is important to consider, however, that its 
increased engagement is built on a long experience as a reliable partner in bilateral and 
multilateral activities in health based on four main strategic pillars: These are: 1) a 
commitment to human rights and 2) a longstanding involvement in health systems 
strengthening in developing countries, led by the Ministry for Economic Cooperation and 
Development (BMZ), 3) dependable support to the UN system and the World Health 
Organisation, led by the Ministry of Health and 4) a preference for building alliances and 
working with others. 
A strong set of identifying features are at the basis of and have ensured the continuity of 
these strategic orientations: 
Continuity in the focus on systematic social protection  
The Bismarckian model of social protection and social health insurance (REF companion 
article) remains at the core of German domestic and international health policy. The 
continuity and impact of this system has had - despite major historical upheavals - a 
profound impact on the values and approaches of Germany's foreign and development 
policy and explains its systems-oriented positions in health. The historical experience “at 
home” with a broad social protection system based on rights and a social health insurance 
system based on solidarity and redistribution, helps understand why Germany has for 
decades been engaged in efforts towards Health Systems Strengthening. It also gives 
support to the Social Protection Floor Initiative which is committed to the human right to 
social security for all36 and it has pushed for intersectoral cooperation between WHO and 
ILO on the links between social protection and health. German NGOs argue that based on its 
historical trajectory Germany should be at the forefront of proposing a new "global social 
contract" which provides a safety net beyond national borders.37 
Continuity of German development cooperation and its unique institutional setup 
Germany's own contribution to international development began already in 1952 in the 
context of the United Nations Development Programme. In 1961, the Ministry of Economic 
Cooperation (BMZ) was established, which like others was initially oriented towards Cold 
War foreign policy goals but significantly changed its orientation (and name) after 
reunification.38 As an independent ministry it has been able to invest in long-term strategies 
and approaches based on human rights principles, driven by technical expertise and built on 
country partnerships. It can depend on two very strong implementing institutions: the 
development agency GIZ (Gesellschaft für Internationale Zusammenarbeit) which is 
focussed on the technical implementation of cooperation projects with approximately 17 
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000 employees – and a financing institution KfW (Kreditanstalt für Wiederaufbau), an 
offspring of the Marshall Plan which supports financial cooperation with developing 
countries. German foreign aid has never been as politically controversial as in other 
countries, it does not need to cater to rapid foreign policy wins or constant domestic 
pressures on "value for money".  
Continuous commitment to the Post World War II development trajectory 
Germany's own post World War II development trajectory remains a guiding principle of its 
development cooperation. Based on the initial support through the Marshall Plan the 
country combined extraordinary economic growth with the expansion of universal social 
protection. The German development approach has always aimed to combine economic 
investment with development aid and the name of the responsible ministry - Ministry for 
Economic Cooperation and Development (BMZ) - reflects this. Many joint initiatives 
between the ministry and German businesses document this mindset and it is also at the 
core of the new strategy of cooperation with Africa – the "Marshall Plan with Africa"39 – that 
the German government has recently proposed. The conflict that can arise between public 
and private sectors goals both in Germany and in partner countries requires more detailed 
analysis, but extends beyond this article. 
Continuous commitment to the principle of multilateral engagement  
German foreign policy considers multilateral engagement as the "most important principle 
for international order." (Steinmeier)40 The geopolitical focus of German development 
engagement is not determined by colonial history in contrast to other European donors 
such the UK and France.41 Only recently, as a consequence of the migrant crisis, has the 
African continent emerged as a clear focus. Multilateralism is understood by Germany as a 
commitment to international cooperation and to working in and through international 
organizations and rule-based systems plus adhering to fundamental norms of the 
international community such as rule of law, human rights, peace and prosperity.42 In global 
health, this is reflected especially in the support to the World Health Organisation, which 
Chancellor Merkel has described as the "only international organisation that enjoys 
universal political legitimacy on global health matters.”43 "Taking leadership" has not been a 
strategic priority. 
These features are reinforced through Germany's G20 agenda where the government 
wishes to set “a course diametrically opposed to isolationism and any return to 
nationalism.”44 This includes the reform of the United Nations and explains why Germany 
engaged so deeply in the WHO reform process - beginning with its membership in the WHO 
Executive Board 2009-12 - and the charge to increase the assessed contributions to the 
WHO.45 This move by the German government is particularly notable in view of the fact that 
assessed contributions have been falling in real terms for the past decade.46 It is a very 
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significant indicator for Germany’s goal to strengthen the autonomy and room for 
maneuver of the WHO. 
To some extent, Germany’s reliance in the multilateral approach to global health can also be 
seen in the channels of ODA spending. On average 54 percent of health-related ODA 
between 2005 and 2015 was channelled through multilateral institutions – similar to other 
European countries such as France and Italy.47 Except for 2015, the multilateral share of 
Germany has remained above 50%. The USA and the UK, on the other hand, channelled only 
17 and 36 percent, respectively, through multilateral organizations in the period between 
2005-15. 
The multilateral and partnership based approach is also reflected in the launch of joint 
initiatives with other global health actors and national partners rather than to initiate high 
profile "leadership" activities on its own; some examples are "Providing for Health” Initiative 
P4H, International Health Partnership and IHP+. In the SDG process the German government 
has advocated for the inclusion of Universal Health Coverage with special reference to 
sexual and reproductive health and rights48 and it is now following through with support of 
the new UHC Alliance. Germany has now become a partner in most of the major global 
health alliances and is now also a major donor of the Global Fund to Fight AIDS, Tuberculosis 
and Malaria (GFATM) and GAVI.  
Figure 2 about here: Stylized timeline of recent developments in Global health in Germany 
(left: key events with impact on Global Health; right: selected German government initiatives 
in Global Health) 
While Germany has taken important steps in stating commitment to multilateralism and 
international organizations with concrete actions, most notably an active involvement in 
governance and an increase in financial contributions, it will now have to show its consistent 
and sustained support on different levels of interaction. The German commitment to 
multilateralism and “working with others” will need to be reflected in the ways in which it 
funds ‘global public goods’ for global health such as the creation of joint systems for 
monitoring and evaluation or data sharing platforms and it will need to continue supporting 
an increase in assessed contributions to the WHO. Germany will also need to step up its 
efforts to increase the number of German professionals - including secondments - working 
for international organizations such as the WHO or the Global Fund.  
5 Aiming for policy coherence and stakeholder involvement in global health  
While some significant steps have been reached in anchoring global health within the 
German federal government, much remains to be done and Germany's record is in no way 
purely positive. Several major conflicts of objectives have become obvious in past policy 
decisions and remain unresolved. One such example is the Framework Convention on 
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Tobacco Control (FCTC). When in 2003, where its role in the drafting of the Framework 
Convention of Tobacco Control was ambivalent if not obstructive. Germany finally agreed to 
sign the FCTC, but the delegation still voiced its reservations against the convention and its 
alleged negative economic consequences.49 The convention eventually entered into force by 
2005,50 but up until today Germany has not yet banned tobacco advertising completely in 
cinemas and building facades51 and implementation of the FCTC is based on the 
implementation of EC directives rather than WHO rulings.52 Germany will need to show 
greater commitment to norm-setting activities and consistency in its positions and values 
across multilateral institutions. 
Despite increasing efforts at coordination, the multiplicity of actors still leads to fragmented 
engagement and weakens the overall impact that German contributions to global health – 
financially and otherwise – could have. There is not yet a strong awareness for global health 
issues within German parliament. It has on occasion debated specific topics related to global 
health (WHO reform,53 tobacco framework negotiations,54,55 AMR,56 Ebola crisis57) and a 
number of parliamentarians show a strong engagement for health development,58 but 
global health challenges have been of limited importance to the work of the committee on 
development policy, notwithstanding their very intersectoral nature.  
Box 1: The structure of global health policy in Germany 
The responsibility of German global health policy lies with the Ministry of Health (BMG) 
which represents Germany at the WHO. The Federal Ministry for Economic Cooperation and 
Development BMZ59 has the responsibility for cooperation with the World Bank, the 
GFATM, UNICEF, and UNFPA. The Federal Foreign office is responsible for humanitarian 
assistance and was the coordinating body for all the activities of the German Government in 
its response to the Ebola crisis. Research and development activities on NTDs and poverty-
related diseases are distributed across the Ministry of Education and Research (BMBF), the 
BMZ, and the BMG (and its research institutes such as the Robert Koch Institute).60 
International activities related to sexual and reproductive health are conducted by the 
Federal Ministry for Family Affairs, Senior Citizens, Women and Youth (BMFSFJ). The Federal 
Ministry for Economic Affairs and Energy BMWI promotes the activities of German health 
and technology companies abroad.  
Germany has centres of excellence in research, professional associations and science 
associations, an active civil society and an innovative health industry but these are not per 
se strong global health actors. It hosts many global health meetings and conferences and 
since 2009 annually organizes the World Health Summit in Berlin. However, there is not yet 
a well-organized and articulate "global health community" with prominent leaders. While 
the voices in the development policy arena are strong there is no well organized global 
health advocacy lobby as in many other countries. In particular, the weakness of German 
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public health institutions and academic teaching and research institutions must be 
mentioned. This too can be traced to some degree to policies of the Nazi regime and its 
abuse of public health and medicine, especially through the concept of racial hygiene.61 
Nevertheless, there have been some important developments towards more policy 
coherence and stakeholder involvement. 
In government a major step towards a more strategic and coherent approach to global 
health was achieved by the adoption in 2013 of Germany's first Global Health Strategy, 
“Shaping Global Health - Taking Joint Action - Embracing Responsibility"62 by the German 
cabinet after a two-year consultation process.  In this concept, the German government 
presents global health as a matter of 14 (!) intersecting policy sector, most importantly 
development, security, trade, economy, human rights, education, migration and 
development.63 As a consequence of the recognition of health as a cross-sectional and 
multilevel governance policy area, the German government has begun step by step to 
establish positions and structures for inter-ministerial collaboration and coordination on 
matters of global health. For example, the position of a Coordinator for the Foreign Policy 
Dimension of Global Health Issues in the Ministry of Foreign Affairs was (also) created in 
reaction to the Ebola crisis.64 Cooperation between the ministries and agencies has 
improved, also reinforced through the role of the chancellery in relation to the global health 
activities of the G7 and the G20 process. The government has also increased its outreach to 
NGOs, the private sector and academia, all of which are presently very much involved in the 
various G20 global health activities linked to  the working groups with representatives from 
business (B20), think tanks (T20), and civil society (C20). 
However, despite the increased political priority towards health, financial commitment is 
still not high enough and Germany falls short of reaching the target of disbursing 0.1% of the 
country’s GNI for global health.65 OECD figures indicate 0.03% of GNI. Thus, while the 
growth of German ODA for health over the past 10 years of 94% indicates strong willingness 
of engagement a gap between political commitments and disbursed ODA remains (see 
figure 3).66 In the period from 2005 to 2015, Germany has only contributed 5.8% of overall 
ODA spending to global health with no significant upwards trend visible. An analysis by the 
German Institute for Development Evaluation (DEval) in 2016 concluded that “German 
health ODA in 2002-2013 has not reflected the level of priority recommended by WHO.”67 A 
global health leader will need to make more funding available and aim to reach 0.1% of 
gross national income (GNI) spent on global health within the near future. At the same time 
- in order to be strategic in the transformative era of the SDGs - it will be critical to gain a 
reliable overview of all channels of German contributions to global health and its 
determinants based on a broader definition of contributions, not only as ODA and not only 
focused on narrowly defined health investments.  
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Link to Web-Appendix: Comparative figures from the Institute of Health Metrics and 
Evalutation 
Figure 3 around here: ODA for health in the G7 countries and their ODA for health-to-GNI 
ratios 
Civil society is becoming more vocal in global health. German development cooperation is 
characterized by a very active and immensely heterogeneous set of civil society 
organizations who have only recently moved into the broader global health agenda. They 
have played a significant role in pushing the German government to support to WHO, 
continue its commitment to UHC, as well as sexual and reproductive health and rights and 
HIV/AIDS. Now the organizations are striving to broaden Germany’s global health agenda, 
linking it more strongly with issues of social justice, exclusion and discrimination, and human 
rights. A strong role is played by the catholic and protestant churches which both have a 
development organisation (Misereor and Brot für die Welt). Global health concerns were 
first voiced by the HIV/AIDS lobby, the activists cooperate in the Action against AIDS 
Germany which has successfully lobbied German policy makers for a more significant role in 
and commitment to the GFATM.68 An important step was taken when VENRO - the umbrella 
association of 120 development-related NGOs - initiated a working group on global health in 
2010 which has contributed to German global health debates and was involved in the 
preparations of the G7/G20 meetings69 including the C20 in 2017. Political foundations such 
as the Heinrich-Böll-Foundation which is linked to the Green Party has been vocal about 
global health, too.70 An innovative new civil society actor is the German Platform for Global 
Health which was founded in 2012 as an association of civil society actors that brings 
together national welfare organizations, trade unions and NGOs that are active in both 
global and national health policy with a strong focus on equity.71  
The German health industry has only recently begun to engage. Germany has a very large 
healthcare market (EUR € 328 billion total volume of the healthcare industry in 2014, with 
an 11.2% share of GDP)72 and a significant and innovative health industry which includes 
large global players which are complemented by many medium-sized companies. Yet, there 
is still significant potential for the German private sector to be a lead contributor to global 
health and innovation and to act responsibly to improve the health of the poorest, 
especially in research and development and pricing of medicines.73 Nevertheless, there are 
forums for cooperation and dialogue: A new strategic alliance is the German Healthcare 
Partnership (GHP) which was established in 2010 jointly by the German Federal Ministry for 
Economic Cooperation and Development and the Federation of German Industries (BDI). A 
new feature is the involvement of non-health private sector companies like Munich Re and 
SAP (with the GFATM) and DHL (e.g. with GAVI) providing support through their core 
business expertise and technology. Within Germany there is close cooperation between 
companies and scientific research facilities and the recently founded German network on 
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Neglected Tropical Disesases (DNTDs) brings together partners from academia, civil society, 
and industry. 
Despite these activities, non-governmental stakeholders in academia, civil society and the 
private sector are still weak as compared to some other G7 countries. A recent study by 
Kaffees and colleagues looks at education and training on global health issues across 
German universities.74 The paper paints a rather sober picture of the German university 
landscape when it comes to training future professionals equipped with the right knowledge 
and skills to address global health issues, particularly when it comes to broader, 
interdisciplinary education and training. The study exposes that “only one-third of medical 
schools and less than a third of all health-related degree programs in Germany offering 
some kind of education in Global Health.”75 Thus, while Germany has been showing 
tremendous eagerness to become more visible across core institutions of global health 
governance, the low prioritization of global health issues in the curricula of its universities 
reflects a gap that needs to be filled as Germany aims to adequately staff its contribution to 
global health. Compared to North America and the UK, Germany is simply outstripped in its 
global health education activities, both in the number and degree options as well as 
research on global health education.76 While the Federal Ministry of Education and Research 
(BMBF) has created some incentives for German universities and researchers to become 
more interdisciplinary in their research on global health issues, for example in the field of 
neglected tropical diseases,77 there needs to be a broader emphasis on global health 
education and training at the level of federal ministries, state ministries and individual 
universities. The identified gap is also an indication of weak professional and scientific 
organisations whose lobby power is not forceful enough. 
There are some mechanisms that help to bring the many global health stakeholders 
together - such as an annual meeting organized by the Ministry of Health, the World Health 
Summit in Berlin and some NGO and academic meetings. One new such initiative is the 
Zukunftsforum Public Health (Forum Future Public Health) which is coordinated by the 
Robert Koch Institute;78 its working group on Global Public Health stresses the need for 
more collaborative research on global health, increased funding for such research, and more 
global health teaching in Germany and abroad.79 Nevertheless, this is not sufficient to create 
a strong and vibrant global health community in Germany.  
 
None of the large German Foundations have prioritized global health leadership. The gap 
has partly been filled by the world's largest global health philanthropy, the Bill and Melinda 
Gates Foundation which has increased its cooperation with German partners significantly, 
for example in February 2017 a memorandum of understanding between the BMGF and the 
BMZ has been signed and several of the G20 preparatory meetings have been supported by 
the foundation.80 The influential role of the foundation in global health policy in general and 
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in Germany in particular81 has been criticized but why exactly German foundations have not 
ventured into the field of global health remains a topic for further research. Only recently 
have there been first indications of greater engagement of foundations on global health 
issues (e.g. Volkswagenstiftung)82  and other institutions such as the German Institute of 
Development (DIE), the Stiftung Wissenschaft & Politik (SWP) and the WZB (a non-university 
research institute). 
6 The global health research and development gap 
Germany boasts strong research organisations such as the universities with its German 
Research Foundation (DFG), Max-Planck-Society (MPG), Helmholtz Society (HGF), Leibniz-
Association (namely the Bernhard Nocht Institute for Tropical Medicine), the German 
Centers for Health Research (DZG), and the Fraunhofer Society. In a ranking of all scientific 
citations from 1999-2009 of Thomson Reuters, the Max-Planck-Society ranked second in the 
world – just after Harvard University.83 The Robert Koch Institute (RKI) is the government’s 
central scientific institution in the field of biomedicine and one of the most important 
bodies for the safeguarding of public health in Germany. The Paul-Ehrlich Institute (PEI) is 
the Federal Institute for Vaccines and Biomedicines. It is a senior federal authority in the 
field of medicinal products providing services in public health. The German Center for 
Infection Research (DZIF) with thematic units on Malaria, Tuberculosis, AIDS and Emerging 
Infections and additional infrastructure units was established in 2012 to align translational 
infection research with the aim of developing new diagnostic, preventative and therapeutic 
methods. Despite the significant research output with relevance for global health, there is a 
greater gap between research activities and the political domain than in many other 
countries including the USA, UK, or France. Activities often remain uncoordinated and no 
reliable overview of all research activities exists. 
Box 2: Germany’s research tradition in global health 
Rudolf Virchow is probably the name that is most frequently mentioned when calling for a 
more profound social and political understanding of public global health. The extent to 
which the rich tradition of German universities with the unity of teaching and research 
contributed to the scientific progress of high relevance to public health and tropical 
medicine is less remembered. Pioneers include Robert Koch, Paul Ehrlich, Bernhard Nocht 
and Theodor Bilharz; German companies were leaders in vaccine and drug development; 
e.g. IG Farben first produced chloroquine, the most successful anti-malarial drug for 
decades. The early discoveries in German chemistry led to the synthesis of anti-infective 
drugs, significant contributions were made to immunology, medical technology and 
research on the causative agents of infectious diseases. Many of the individuals involved 
contributed to the health programs of the League of Nations and helped build institutions in 
developing countries. This leadership in so many fields was destroyed through the atrocities 
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of the NS regime and the holocaust (the earlier mentioned IG Farben, for example, was the 
producer of Zyklon B). 
Germany presently invests 3% of its Gross National Product on research and development84 
and has a rich research and development tradition in health85,86 but it has been a late comer 
in the research field on poverty-related diseases. In 2010, the Federal Government’s Health 
Research Framework Programme made the funding of research and development on 
neglected and poverty-related diseases a priority area. 87;88,89 Germany has since increased 
its funding for neglected diseases, albeit from a low starting point, to US $54 million (0.015% 
of GDP) in 2014, placing it 5th behind the USA (0.088%), the UK (0.046%), Switzerland 
(0.029%) and France (0.026%).90,91  
To address coordination and policy coherence the Ministry of Education and Research in 
2014 presented a list of measures for how to improve cooperation with African countries in 
the field of health research and education – in particular with higher education institutes 
and in the professional and advanced vocational training.92 In December 2015, the Ministry 
of Education and Research published the strategy for promoting health research in the 
relevant fields - especially NTDs - until 2020. Programmes aim to a) pool the activities in the 
field of infection research and to create research capacities that meet international 
standards and promote Germany as a high-ranking scientific location that will be attractive 
to young scientists from around the world. and b) support to product development 
partnerships (PDPs) to develop products for prevention, diagnosis or treatment of neglected 
tropical diseases or diseases that primarily affect children in the poorest regions. The 
funding is planned to be increased to up to EUR 50mn for the second round of funding.93 
Germany does not yet live up to the SDG target 3b commitment that calls for support to 
research and development for diseases affecting predominantly developing countries and 
prioritizing public health needs over intellectual property rights by respecting the Doha 
declaration and making use of the flexibilities within the Agreement on Trade-Related 
Aspects of Intellectual Property Rights (TRIPS). German NGOs underline that access to 
medicines is a core obligation under the right to health, as well as an essential part of UHC.94 
The German government has not been very active in this domain. In particular, 
recommendations of the WHO Commission on Public Health, Innovation and Intellectual 
Property Rights in 2003 and the Consultative Expert Working Group (CEWG) in 2013 to 
establish a global health R&D fund was rejected by the German government. Moreover, the 
government’s response to the 2016 UN High-Level Report on Access to Medicines (UN 2016) 
is still outstanding.  
7 The next turning point: refugees and migration 
The influx of 1.2mn refugees in 2015 and 2016 represents a turning point in how German 
policy makers regard foreign affairs and development policies and the interconnectedness 
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between the global and the local. As in the field of health security, the distinction between 
domestic and foreign policy is becoming ever more fluid in relation to refugee and migrant 
health. During the budget debate in 2016, Angela Merkel raised that point by saying that the 
security, welfare, and prosperity of German citizens, but also of citizens of other nations, are 
dependent on how Germany acts.95 The chancellor was highly praised internationally for her 
initial humanitarian response to the crisis but has faced increasing opposition within 
Germany and Europe from all sides of the political spectrum.  
So far, Germany has failed to live up to its aspirations as an innovator and global health 
leader in relation to migration and refugee health. Germany delayed addressing migrant 
health in policymaking efforts for a long time. Consequently, Germany ranks only 22nd out of 
38 countries in the MIPEX health score (a summary indicator for entitlement and access to 
health services),96 below average compared to countries with comparable migrant 
populations and GDPs, deeming the country “only halfway favourable from an integration 
perspective”.  
More recently a political response has been to increase the investment in the countries of 
origin - which makes Africa a pivotal strategic focus of a new “global development policy.”97 
The BMZ outlined points for a new strategy for cooperation with Africa – the so-called 
“Marshall Plan with Africa” – in January 2017 in which it also highlights the role of social 
protection and of investment in health. The BMZ also invests in rebuilding health 
infrastructure in Northern Iraq and Syria. The German Minister of Health explicitly 
mentioned weak health systems as a reason for people to leave their country and to seek a 
better life in Europe.98 But recent actions at the political level such as the EU refugee 
agreement with Turkey - in which Germany played a major negotiating role - have been 
heavily criticized also for their health impacts.99  
In this context, the BMZ saw an increase of its overall budget from EUR 6.5bn in 2015 to EUR 
7.4bn in 2016. In November 2016, the German Parliament approved another increase in 
BMZ’s budget by EUR 1.1bn reaching a total budget of EUR 8.5bn for 2017.100 And most 
recent budget plans by the Ministry of Finance indicate an additional slight increase of EUR 
200mn for 2018.101 The priorities behind this increase include, “above all, efforts to address 
the refugee crisis within and around Syria and to give young people in Africa a better 
future.” 102 
The access to health services provided to migrants in Germany therefore stands in contrast 
to the Germany’s advocacy efforts for UHC internationally. German NGOs have repeatedly 
called on the government to regard and implement the human right to health within 
Germany in the same way it is expressed in its development policies.103 They call for the 
current contradiction between UHC and entitlement restrictions for asylum seekers to be 
resolved, and that access barriers for all migrants be removed. This also applies to 
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Germany’s role within the EU. If Germany strives to be a reliable backbone of global health 
efforts and to be considered a credible “norm-entrepreneur”, it needs to be more 
consistent in its compliance with human rights standards and universal access to health 
care.  
8 Becoming a leader  
A set of recommendations on the strengthening of global health were presented to the 
German Chancellor in March 2017 on occasion of the Science20 Dialogue.104 Germany is 
now a strong contributor to global health. There is significant potential for its political 
commitment to multilateralism, human rights, and solidarity to be turned into concrete 
action and expectations are high. But in order to have a decisive and sustained impact on 
global health Germany will have to give stronger attention to structural issues that drive 
health development. This is reinforced by the SDGs call for approaches that reflect the 
interface of domestic challenges with global responsibilities and the need to act beyond just 
the health sector.  
Germany has underlined that that in order to resolve global health issues the world needs 
strong multilateral institutions. As a strong advocate for multilateralism it should also 
demand increased innovation, policy coherence and accountability from the multilateral 
system – and it should be prepared to show how such coherence can be assured in its own 
actions inside and across international institutions. The outstanding role that the German 
government has played in supporting the WHO and the UN at large must be continued and 
strengthened. Germany should contribute to productive and pluralist dialogue on what 
constitutes global health, global public goods and global health governance.  
But it is important for Germany to be better prepared for challenges in global health which 
are related to other big shifts underway: reform of multilateralism, new financing 
mechanisms and the transformative strategies of the SDGs. Germany should position itself 
as committed to innovative and multisectoral global health partnerships based on the 
transformative thinking associated with SDG implementation. Global positioning will include 
innovative proposals and the forging of new health alliances, not only in the usual Western 
donors’ group but with new partners in Africa, Asia and in particular with China which is 
emerging as a key global health player.105 
2017 is in an election year in Germany. Over the next few months all political parties should 
be challenged by the major stakeholders to present their global health positions. As of 
October 2017 the successful political parties will begin to negotiate coalition agreement that 
will be decisive for the next four years. From this analysis, the following priority actions and 
strategic orientations emerge:  
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The new German government should make it a priority to update the German Global 
Health Strategy and transform it into a determined strategic commitment for its period of 
office adopted by the cabinet and with the personal commitment of the chancellor.  
At the core of such a renewed strategy lies the commitment by Germany to continue on its 
path to significantly increase its global health funding - the new government should set the 
goal that at the end of its term in autumn of 2021 it would have achieved the hallmark of 
0.1% GNI for global health funding. Germany’s call during the 68th World Health Assembly 
for increasing Member States’ contributions to the assessed budget by 10% to the WHO 
needs to be repeated tenaciously – a call that is strongly supported by the civil society group 
(C20).106 This is all the more important as the extent to which the US will support 
multilateralism and UN organisations such as the WHO and continue to finance large global 
health programmes is uncertain.  
The renewed global health strategy would assign clear responsibilities and accountability, 
as well as include transparency of all funding streams that contribute to Germany's global 
health activities. It should ensure policy coherence and not shy away from controversial 
policy areas. It should support the establishment of a stable base of institutions, expertise 
and advocacy outside of government. A broad consultation process should form part of 
process. A parliamentary committee on global health should follow-up on the global health 
strategy of the government, monitor its implementation, bring new proposals into 
parliament and ensure accountability of the government.  
The strategy would reinforce Germany's longstanding commitment to health systems 
strengthening which is critical for the implementation of the UHC agenda and ensure that 
it is fully reflected in its approaches to preparedness and response to health crisis and AMR. 
German initiatives such as Healthy Systems - Healthy Lives have a significant potential for 
catalyzing UHC innovation and should be taken forward with significant investment.107 This 
This should include support to improved monitoring and analysis of HSS activities nationally 
and globally108 and to the support of interdisciplinary approaches to health that broaden the 
perspective towards economic, social, cultural and political determinants of global health in 
this context. 
Poverty-related diseases and neglected tropical diseases should be an obvious priority for 
the German government’s new strategy of cooperation with Africa (“Marshall Plan with 
Africa”) - next to the existing areas of German global health focus. By improving research, 
development, and innovation in this field the German government can reach the poorest 
groups within those society and build lasting health research and education infrastructure. 
Institutional support for research and education centres in Africa are an important element 
to create research capacities within Africa that meet international standards and become 
high-ranking scientific locations that will be attractive to young talent. Germany can build 
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here on already existing cooperations between African partners and institutions such as the 
BNITM, the German Center for Infection Research (DFIZ) and the related institutions within 
the DZIF network. In order to achieve a viable solution in the long-term, greater coordination 
and cooperation between the three leading German ministries engaged in development 
policy on neglected tropical diseases and poverty related diseases (BMBF, BMZ, BMG) is 
needed. Establishing an institutionalized working group could addresses short and long-term 
needs for comprehensive NTD control and elimination.  
By including migrant and refugee health in a revised global health strategy Germany could 
make a determined contribution to global health by applying the concept of “globalization 
within” 109, or that “global health starts at home”110 with the appreciation that immigration 
is an organic component of the spatial unit of a social ‘one world’.111 Fully involving migrant 
nongovernmental organizations in strategy development efforts rather than to developing 
policies about migrants would be a clear step towards recognizing migrant health as an 
inherent part of global health.112 
Germany should initiate an update of the EU lobal Health Strategy. The European 
Commission Communication on global health from 2010 outlines the EU's vision in various 
aspects of global health, such as governance, access to health services, the policymaking 
process and health research.113 Since then a significant number of events has moved the 
global health agenda and the EU's role forward, for example in the area of health security. 
This includes the German-French initiative in 2016 to establish the European Medical Corps 
to improve the EU's ability to respond to health crisis.114 Action is required in many different 
areas of the work of the European Commission - especially in development, research and 
innovation and health and related policy coherence as well as on the determinants of health 
i.e. EU trade policies. Germany can play an important role in moving this forward. It can also 
engage more actively in European initiatives such as the European and Developing Countries 
Clinical Trial Partnership EDCTP. 
Germany cannot strengthen its position in the global health architecture without being 
prepared to invest domestically. The central government as well as science funding bodies 
and foundations need to take action in order to strengthen national institutions and 
domestic mechanisms in order to enhance its capacities and expertise on matters of global 
health. It needs some form of a national "Global Health Initiative" as proposed by The 
Leopoldina, the German Academy of Sciences in 2015.115 This must include the broadening 
of education, training and research in global health which pays heed to social and cultural 
sciences and encourages interdisciplinary exchange between the life sciences and the social 
sciences.116 German foundations should enter this arena, especially for policy and social 
science research. They could also support an enabling network or platform to build 
synergies between the many institutions, to create a global health institute or think tank, to 
establish a Global Health Society or a Berlin Global Health Hub, to commission a regular 
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Global Health Report so as to provide an overview of German activities and contributions. 
Cooperation with leading institutions in other countries - including developing countries - 
should be encouraged, exchange and conferences such as the World Health Summit should 
be strengthened. 
Germany as a major economic powerhouse must give more priority to addressing the 
determinants of health and ensuring global public goods. The German Platform for Global 
Health, for example, calls for a broad global health agenda that emphasizes health as a 
social or socio-political issue. Germany has in the past - for example - repeatedly argued for 
a financial transaction tax, but has not been successful in gaining political support from 
other key countries. Since many of these issues relate to policies that also reside with the 
European Union it has to link its global health priorities with positions on EU policies. 
Germany must take on the challenge to become a leader on migrant and refugee health, 
developing innovative multi-sectoral approaches both for migrants and refugees in Germany 
as well as in third countries.  
The upcoming German elections in September 2017 will be critical. The continuity of 
Germany's trajectory in global health as an important field of multilateral cooperation and 
development policy will hopefully be ensured and leadership and investment expanded, 
even if a new coalition and new individuals come to power. Ten years of activity in global 
health have created expertise and commitment in many different ministries and at different 
levels of government and with other actors and stakeholders. This bodes well for a 
continuation. It will be critical to ensure that a new government keeps and strengthens the 
global health commitment. Indeed, Germany will be called on to be a strong global health 
leader by cause of circumstance – politically, conceptually, and financially. By stepping up it 
will make a significant contribution to the implementation of the Sustainable Development 
Goals.  
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